Cold Plasma Market size was over USD 4.03 billion in 2024 and is projected to cross USD 36.8 billion by the end of 2037, growing at more than 18.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of cold plasma is estimated at USD 4.63 billion. The growth of the market can be attributed to surge in people affected by chronic wounds. The prevalence of chronic wounds is high among people suffering from various chronic disease. Therefore, with the growing prevalence of chronic disease, the risk of chronic wound increases. In 2022, the global prevalence of chronic wounds was forecast to be 1.51 to 2.21 per 1000 people. However, the frequency is anticipated to increase as populations around the world get older. Therefore, the demand for cold plasma is estimated to increase, since it has proved to be effective in healing wounds.
Moreover, the prevalence of spread of infection in hospitals is also high. Hospital acquired infections (HAIs) are important issues that require urgent attention on a global scale. HAIs are a class of infections that a patient did not have prior to being admitted to the hospital. HAIs don't even exist during the latency period; instead, they appear within few hours of a patient admitting the hospital. The fifth most frequent type of illness related with healthcare is urinary tract infections (UTIs). At some point during their hospital stay, 12%–16% of adult inpatients would have an indwelling urinary catheter (IUC). For every day the IUC is present, a patient's chance of developing a catheter-associated urinary tract infection increases by 3%–7%. Hence, for the purpose of eliminating all varieties of harmful microorganisms, cold plasma may serve as a valuable tool.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
18.3% |
|
Base Year Market Size (2024) |
USD 4.03 billion |
|
Forecast Year Market Size (2037) |
USD 36.8 billion |
|
Regional Scope |
|
Industry (Polymer & Plastic, Textile, Electronics & Semiconductors, Food & Agriculture, Medical)
The global cold plasma market is segmented and analyzed for demand and supply by industry into polymer & plastic industry, textile industry, electronics & semiconductors industry, food industry & agriculture, and medical industry. Out of which, polymer & plastic industry segment is anticipated to garner the highest revenue by the end of 2037. The growth of the segment can be attributed to growing production of polymers & plastics. An about 3 percent rise annually was projected for 2021 to bring the total production of plastics to about 389 million metric tons across the globe. Hence, the demand for cold plasma is growing in this industry. Cold plasma treatment is a unique process that alters the surface of the polymer, allowing for the development of packaging materials with specified properties. Further, owing to its characteristics influenced by cold plasma this polymer & plastics are extensively preferred in medical sector. Syringes, catheters, and surgical gloves are just a few of the low-cost, disposable tools and equipment that are made possible by polymers.
Regime (Atmospheric Cold Plasma, Low-Pressure Cold Plasma)
The global cold plasma market is also segmented and analyzed for demand and supply by regime into atmospheric cold plasma, and low-pressure cold plasma. Amongst which, the atmospheric cold plasma segment is anticipated to have a significant growth over the forecast period. A promising technique called cold atmospheric plasma (CAP) has great potential for usage in a variety of fields, including biotechnology, biomedicine, textiles, and food processing. Plasma technology's ingenious design has the ability to revolutionize these sectors in every manner. Technically, this CAP technology is a green process since it produces no chemicals that are hazardous to the environment or the economy. Moreover, growing prevalence of chronic wound is also estimated to boost the growth of this segment. Given its simplicity of use and non-invasiveness, this approach has been praised and encouraged for use in a variety of therapeutic regimes, including those for cancer, ulceration, and wound healing. Hence, this factor is estimated to boost the growth of the segment further boosting the market growth.
Our in-depth analysis of the global cold plasma market includes the following segments:
|
By Industry |
|
|
By Regime |
|
|
By Application |
|
North American Market Forecast
The share of cold plasma market in North America, amongst the market in all the other regions, is projected to have the highest growth by the end of 2037, backed by surge in healthcare expenditure, along with growing prevalence of cancer among people in this region. In the United States, 1,752,735 new cases of cancer were reported in 2019, while 599,589 people passed away from the disease. 439 new cases of cancer and 146 cancer-related deaths were reported for every 100,000 persons. Furthermore, it is projected that over the course of the forecast period, the cold plasma market would rise as a result of companies putting more of an emphasis on using cold atmospheric plasma technology to treat a variety of chronic diseases and ailments. Also, the increased prevalence of dental caries cases would probably increase demand for non-drilling, efficient treatments that also retain patient comfort. This would enhance demand for cold plasma therapy, and further support the market's expansion in this region.
APAC Market Statistics
The Asia Pacific cold plasma market is estimated to be the second largest, to have the highest growth. The usage of cold plasma in medical procedures, a rise in hospital-acquired infections (HAI), and the development of novel cold plasma cancer treatment techniques in the Asia Pacific area are all contributing reasons to the market growth for cold plasma equipment. In biomedicine, cold plasma has proven to be quite effective. Cold plasma is utilized in a variety of medical procedures in Asia Pacific, including wound healing, cancer treatment, dermatology, atmospheric plasma on oxidative stress, inflammation, and diabetes-induced enzyme glycation, as well as disinfection and scar removal. Chronic wounds benefit from cold plasma's capacity to kill bacteria, particularly drug-resistant bacteria, to prevent further infection. This speeds up the healing process of the wound and avoids any additional difficulties or uncomfortable side effects. Although there are numerous different techniques to treat wounds, cold plasma therapy is anticipated to be one of the most efficient options and they are most preferred by people living in this region.
Europe Market Forecast
Additionally, the cold plasma market in Europe region is also estimated to have the significant growth over the forecast period. The growth of the market in this region can be attributed to presence of key players in this region. Hence, owing to these key players the Europe plays an important role for cold plasma as compared to other regions. These key players are further boosting their production in order to satisfy the demands of various organization. Also, the trials of cold plasma on various disease in this region is growing, which is also estimated to boost the growth of the cold plasma market.
A world leader in plasma processing technology, Nordson MARCH, a Nordson Corporation company, announced the launch of their FlexTRAK-SHS automated plasma treatment system. The 9.6-liter (585 in3) large-volume F3-S process chamber found in the plasma system was expected to treat more strips per cycle or accommodate larger strips, which would result in higher throughput and increased productivity for semiconductor and electronics packaging.
Apyx Plasma Technologies, the maker of Renuvion, a patented helium plasma and radiofrequency technology, has announced the release of the Apyx One Console, their latest-generation Renuvion generator, in the United States.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?